Objectives: Breast cancer is the cancer with the highest incidence in women in Brazil. The revelation of this diagnosis is considered a crucial moment, responsible for uncertainties and even affecting the doctor–patient relationship. Although the communication of bad news is one of the most frequent practices among physicians, difficulties are common. The aim of this study was to evaluate the influence of the communication in the diagnosis of breast cancer and the repercussions on the treatment, using the parameters as suggested by the Centro Avançado de Diagnóstico de Câncer de Mama (CORA/ HC-UFG) in Goiânia-GO. Methodology: This qualitative and integrative study was conducted in the following databases: PubMed, SciELO, and MedLine with six selected articles. The keywords used were “communication,” “diagnosis,” “breast cancer,” “adherence to treatment,” and “doctor–patient relationship.” Based on the results, a comparison was made with the one carried out in the CORA/HC-UFG. Results: Through the analysis of the articles, it was observed that the no tification of the diagnosis of cancer is considered a critical moment and how professionals notify patients directly interferes in the relationship of the patients with the diagnosis itself. Thus, it is up to the professionals to provide psychological and informative support at the time of diagnosis in order to reduce pessimistic feelings and to avoid abandoning the medical–hospital follow-up. In addition, when analyzing the care provided at CORA, it was noted that the adoption of a more humanized and multiprofessional communication, with the help of the psychological team, it was noticed, in agreement with the studies, a better acceptance and treatment adherence. Conclusion: The notification of cancer should be done in the most empathetic way possible, using techniques of psychology and communication, so that the patient receives information about his health situation in a welcoming manner. Furthermore, although the diagnostic communication is a medical act, the presence of a psychologist to support the patient has shown benefits.

Objectives:To report the experience of the Liga da Mama (Breast League) of the UFG in the Academic Leagues Meeting (ELA) and the findings found during the service to the population. Methods: During the event, the Breast League developed a single questionnaire to compose a final database. We inquired about the personal and family history of breast cancer, as well as risk factors such as hormone therapy, and prevention, such as total breastfeeding time. All women over 40 or who had a personal or family history of breast cancer were referred for physical examination, performed by a medical professional in a suitable room. Results: 65 women between the ages of 13 and 86 years were attended at the Information Stand of the Breast League. Of these, 57 had some risk factor (age over 40 years, family history of breast cancer, hormone replacement therapy for more than 5 years, or palpable nodules) and were referred for physical examination of the breasts. 4 women refused physical examination, therefore 53 were examined. At the examination, 6 women had some findings: 2 benign findings of the right accessory breast and 4 suspect findings (1 adolescent 13 years old with bilateral periareolar scaly lesions, 2 females over 40 years with fixed nodules in the lower left quadrant, and 1 female with crystalline papillary discharge on the right). All women with suspected findings were referred to the local health service. Conclusion: The action developed by the Breast League met its primary objectives: promoting the health and well-being of the population, through preventive and educational, humanized, and multidisciplinary activities, providing knowledge and experience to every academic body that compose it. In addition, the League was able to use practical methodologies to give, to the collected data, applicability in scientific productions.

Methodology: This is a narrative review study. The search for articles was done on platforms such as SciELO, PubMed, and Scholar. The period of coverage used in the search was from 2011 to 2019, having as descriptors: breast cancer, prevention, and exercise. Objectives: To demonstrate the relevance of the recommendation of the practice of physical activities as an indispensable factor in the prevention of breast cancer in a manner proportional to the recommendation of exams. Results: Mammography is currently the most preferred form of prevention by physicians and the media. Since the 1980s, when introduced in European countries, the United States, and Canada, clinical trials indicated that mammography screening reduces mortality by 20 to 30% of this pathology. However, recent independent panels show that this rate is only 20% and that it is accompanied by ill effects, such as overdiagnosis. Mammography is undoubtedly an important tool in the prevention of breast cancer and the screening of physicians. However, since cancer arises from the interaction of endogenous and exogenous factors, with lifestyle being the most expressive factor, there should be a greater focus on physical activities, since they reduce the serum levels of some hormones, such as insulin. In turn, these hormones, at high levels, stimulate the growth of tumors. Conclusion: This review evidences the practice of physical activities as essential in the prevention of breast cancer. Without replacing mammography as a preventive method, the exercises are effective in reducing the development of tumors and stimulating physiological recovery without the ill effects of mammography. Therefore, about one-third of all cancers can be prevented with healthy eating and physical activity, which shows that for prevention, physical exercise is as effective as mammography, but much less publicized.

Introduction: Breast cancer is the most common cause among women, with invasive ductal carcinoma (ICD) being the most prevalent and having great phenotypic and genotypic heterogeneity and the ability to metastasize. In turn, mastitis is an inflammation in the breast region, infectious or noninfectious causes, most commonly affecting lactating women. Objectives: It is intended to report a case of ICD accompanied by infectious mastitis and its reverberations. Case Report: A 27-year-old woman presents with a clinical history of mastitis in her left breast that occurred about 3 months ago after weaning her son. She also explained about the use of antibiotic therapy, multiple previous drainages, and local complication with engorgement, edema, erythema, and purulent drainage in the surgical ostium of the left breast. A new drainage and material collection was carried out. Computed tomography of the chest indicated a solid heterogeneous lesion, dense, irregular contours, with areas of air trapping, liquefaction, and cleavage plane with the left pectoralis major muscle and ipsilateral axillary adenomegaly. Pathological pathology confirmed the hypothesis of neoplasia, indicating grade III ICD in comedonecrosis. Immunohistochemistry demonstrated triple-negative character and culture, positivity for Corynebacterium renale. She started neoadjuvant chemotherapy with reduced breast volume and absence of secretion today. Discussion: This is a common and problematic situation in health systems. Repeated outpatient referrals, invasive processes without resolution, aggravating the patient’s case. Moreover, it is noted that mastitis has delayed the diagnosis of the neoplasm, which, depending on the delay, may result in a worse prognosis or a more aggressive or expensive treatment. Conclusion: The diagnostic investigation of neoplasms is of great importance in case of prolonged mastitis not responsive to treatment, due to the fact that many mastitides may come from neoplastic processes that generate the lesion, which can make this injured area conducive to bacterial proliferation.

Introduction: Progression-free survival in patients with HER2-positive breast cancer was significantly improved after administering dual block (DB) associated with docetaxel when compared with trastuzumab and docetaxel. This case report is about a patient with malignant breast cancer — HER2 positive — and metastatic lung and liver disease. Objective: The aim of this study is to report the positive response to the oncologic treatment. Case Report: A 43-year-old woman was diagnosed in 2011 with malignant breast cancer in early stage, i.e., cT1N0M0, with acute liver lesion not detected by tomography. She underwent upfront surgery, adjuvant chemotherapy with AC-TH schedule plus 1 year of Herceptin, and adjuvant radiotherapy. The tumor was developed again in 2015 through physical examinations, revealing metastatic lung and liver disease. She underwent first-line chemotherapy with docetaxel, Herceptin, and pertuzumab with DB maintenance. After additional physical examination, she presented an excellent response to treatment, remaining on maintenance with DB since October 2015 with an exceptional response to oncologic therapy. Discussion: It was observed an excellent response to treatment. Despite the poor prognosis, the patient presented a complete clinical improvement, and the treatment ensured much longer than average survival and an outstanding quality of life. Conclusion: Using docetaxel, Herceptin, and pertuzumab in patients with breast cancer, HER2 positivity improved the median overall survival of the patient; this confirms, albeit as an isolated case, the data from the Cleopatra study.